Literature DB >> 32205967

Presentation and Management of Dermatofibrosarcoma Protuberans: a Single Center Protocol.

Harish Verma1, Karan Sehgal1, Karnav B Panchal2, Santam Chakraborty3, Bivas Biswas4, Geetashree Mukherjee5, Divya Midha5, Gautam Biswas2.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a slow growing dermal tumor with a very low metastatic potential but with significant subclinical extension and capacity for local destruction with local recurrence rates ranging from 0 to 50%. Controversy exists regarding margin width and excision techniques, with some advocating Mohs surgery and others wide excision. We reviewed the excision technique along with the recurrence rates at a tertiary care center in eastern India. This study is a retrospective review of patients with DFSP from June 2011 to September 2018. Patients had initial wide excision using 2-3 cm margins with primary closure or reconstructive procedure; re-excision was done for positive margins. Pathologic analysis included en face sectioning. We evaluated margin width, number of excisions, reconstruction methods, radiation, and outcomes. A total of 31 patients with DFSP (15 males, 16 females), median age 41 years (range 14-82), were treated. Locations were extremities (13), trunk (12), and head and neck (06). The median number of excisions to achieve negative margins was 1 (range 1-3). Closure techniques included primary closure (13; 42%), tissue flaps (13; 42%), and skin grafting (05; 16%). There were 11 patients who received postoperative radiation, 4 for positive margins after maximal surgical excision. At a median follow-up of 24 months (range 1-72), 2 patients (6.5%) recurred locally, and 1 patient (3.2%) had lung metastasis. Using a standardized surgical approach including meticulous pathologic evaluation of margins, low recurrence rate (10%) was achieved with adequate margins (2-3 cm). © Indian Association of Surgical Oncology 2019.

Entities:  

Keywords:  DFSP; Dermatofibrosarcoma protuberans; Fibrosarcoma; Soft tissue sarcoma

Year:  2019        PMID: 32205967      PMCID: PMC7064730          DOI: 10.1007/s13193-019-01007-3

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  18 in total

Review 1.  A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.

Authors:  Christine A Liang; Anokhi Jambusaria-Pahlajani; Pritesh S Karia; Rosalie Elenitsas; Paul D Zhang; Chrysalyne D Schmults
Journal:  J Am Acad Dermatol       Date:  2014-04-19       Impact factor: 11.527

2.  Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Authors:  W B Bowne; C R Antonescu; D H Leung; S C Katz; W G Hawkins; J M Woodruff; M F Brennan; J J Lewis
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

3.  Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.

Authors:  D Monnier; C Vidal; L Martin; A Danzon; F Pelletier; E Puzenat; M P Algros; D Blanc; R Laurent; P H Humbert; F Aubin
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-11       Impact factor: 6.166

4.  Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

Review 5.  Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature.

Authors:  H Voth; J Landsberg; T Hinz; J Wenzel; T Bieber; G Reinhard; T Höller; C-M Wendtner; M-H Schmid-Wendtner
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-06-04       Impact factor: 6.166

6.  Radiotherapy in the treatment of dermatofibrosarcoma protuberans.

Authors:  Roi Dagan; Christopher G Morris; Robert A Zlotecki; Mark T Scarborough; William M Mendenhall
Journal:  Am J Clin Oncol       Date:  2005-12       Impact factor: 2.339

7.  Dermatofibrosarcoma protuberans of the head and neck.

Authors:  A Stojadinovic; H M Karpoff; C R Antonescu; J P Shah; B Singh; R H Spiro; W Dumornay; A R Shaha
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

Review 8.  Dermatofibrosarcoma protuberans: treatment and prognosis.

Authors:  E J Rutgers; B B Kroon; C E Albus-Lutter; E Gortzak
Journal:  Eur J Surg Oncol       Date:  1992-06       Impact factor: 4.424

9.  Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins.

Authors:  S Ten Heuvel; A Suurmeijer; E Pras; R J Van Ginkel; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  2009-07-31       Impact factor: 4.424

10.  CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.

Authors:  J R Goldblum
Journal:  Arch Pathol Lab Med       Date:  1995-03       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.